TOKYO -- The coronavirus competition between the U.S. and China goes beyond developing a vaccine, as both countries aim to accelerate that process to unprecedented speeds in hopes of starting large-scale production by autumn.
America's Moderna raises hopes with initial result, but Beijing ahead in trials
TOKYO -- The coronavirus competition between the U.S. and China goes beyond developing a vaccine, as both countries aim to accelerate that process to unprecedented speeds in hopes of starting large-scale production by autumn.